CRYO-CELL INTERNATIONAL, INC. APIC, Share-based Payment Arrangement, Recognition and Exercise
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of $64.90 thousand for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Notes › Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2026-05-31 was $64.90K, a 62.15% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2026-02-28 was $158.55K, a 46.69% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2025-11-30 was $42.90K, a 71.34% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2025-08-31 was $36.78K, a 74.80% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. apic, share-based payment arrangement, recognition and exercise for fiscal 2025 was $417.10K, a 46.60% decline from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. apic, share-based payment arrangement, recognition and exercise for fiscal 2024 was $781.13K, a 4.35% decline from fiscal 2023.
- CRYO-CELL INTERNATIONAL, INC. apic, share-based payment arrangement, recognition and exercise for fiscal 2023 was $816.64K, a 77.01% increase from fiscal 2022.
- CRYO-CELL INTERNATIONAL, INC. apic, share-based payment arrangement, recognition and exercise for fiscal 2022 was $461.35K, a 52.96% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 6 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 9 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 12 month |
|---|---|---|---|---|
| 2026-05-31 | $64.90K 10-Q · filed 2026-07-15 | $223.45K 10-Q · filed 2026-07-15 | $266.36K derived: sum of 3 quarters · filed 2026-07-15 | $303.14K derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-02-28 | $158.55K 10-Q · filed 2026-04-14 | $201.45K derived: sum of 2 quarters · filed 2026-04-14 | $238.23K derived: sum of 3 quarters · filed 2026-04-14 | $278.26K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-11-30 | $42.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $79.68K derived: sum of 2 quarters · filed 2026-02-27 | $119.71K derived: sum of 3 quarters · filed 2026-07-15 | $417.10K 10-K · filed 2026-02-27 |
| 2025-08-31 | $36.78K 10-Q · filed 2025-10-15 | $76.81K derived: sum of 2 quarters · filed 2026-07-15 | $374.20K 10-Q · filed 2025-10-15 | $523.89K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-05-31 | $40.03K 10-Q · filed 2026-07-15 | $337.42K 10-Q · filed 2026-07-15 | $487.11K derived: sum of 3 quarters · filed 2026-07-15 | $633.05K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-02-28 | $297.39K 10-Q · filed 2026-04-14 | $447.08K derived: sum of 2 quarters · filed 2026-04-14 | $593.03K derived: sum of 3 quarters · filed 2026-04-14 | $771.16K derived: sum of 4 quarters · filed 2026-04-14 |
| 2024-11-30 | $149.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $295.63K derived: sum of 2 quarters · filed 2026-02-27 | $473.77K derived: sum of 3 quarters · filed 2026-02-27 | $781.13K 10-K · filed 2026-02-27 |
| 2024-08-31 | $145.94K 10-Q · filed 2025-10-15 | $324.08K derived: sum of 2 quarters · filed 2025-10-15 | $631.43K 10-Q · filed 2025-10-15 | $806.38K derived: sum of 4 quarters · filed 2025-10-15 |
| 2024-05-31 | $178.14K 10-Q · filed 2025-07-15 | $485.49K 10-Q · filed 2025-07-15 | $660.44K derived: sum of 3 quarters · filed 2025-07-15 | $832.54K derived: sum of 4 quarters · filed 2025-07-15 |
| 2024-02-29 | $307.36K 10-Q · filed 2025-04-14 | $482.30K derived: sum of 2 quarters · filed 2025-04-14 | $654.40K derived: sum of 3 quarters · filed 2025-04-14 | $810.82K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | $174.95K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $347.05K derived: sum of 2 quarters · filed 2025-02-28 | $503.46K derived: sum of 3 quarters · filed 2025-02-28 | $816.64K 10-K · filed 2025-02-28 |
| 2023-08-31 | $172.10K 10-Q · filed 2024-10-15 | $328.52K derived: sum of 2 quarters · filed 2024-10-15 | $641.69K 10-Q · filed 2024-10-15 | $792.59K derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | $156.42K 10-Q · filed 2024-07-15 | $469.59K 10-Q · filed 2024-07-15 | $620.50K derived: sum of 3 quarters · filed 2024-07-15 | $781.58K derived: sum of 4 quarters · filed 2024-07-15 |
| 2023-02-28 | $313.17K 10-Q · filed 2024-04-15 | $464.08K derived: sum of 2 quarters · filed 2024-04-15 | $625.16K derived: sum of 3 quarters · filed 2024-04-15 | $742.62K derived: sum of 4 quarters · filed 2024-04-15 |
| 2022-11-30 | $150.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $311.99K derived: sum of 2 quarters · filed 2024-02-28 | $429.45K derived: sum of 3 quarters · filed 2024-02-28 | $461.35K 10-K · filed 2024-02-28 |
| 2022-08-31 | $161.08K 10-Q · filed 2023-10-12 | $278.55K derived: sum of 2 quarters · filed 2023-10-12 | $310.44K 10-Q · filed 2023-10-12 | $378.19K derived: sum of 4 quarters · filed 2023-10-12 |
| 2022-05-31 | $117.46K 10-Q · filed 2023-07-14 | $149.36K 10-Q · filed 2023-07-14 | $217.10K derived: sum of 3 quarters · filed 2023-07-14 | $298.40K derived: sum of 4 quarters · filed 2023-07-14 |
| 2022-02-28 | $31.90K 10-Q · filed 2023-04-21 | $99.64K derived: sum of 2 quarters · filed 2023-04-21 | $180.94K derived: sum of 3 quarters · filed 2023-04-21 | $248.69K derived: sum of 4 quarters · filed 2023-04-21 |
| 2021-11-30 | $67.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $149.04K derived: sum of 2 quarters · filed 2023-02-28 | $216.80K derived: sum of 3 quarters · filed 2023-02-28 | $301.62K 10-K · filed 2023-02-28 |
| 2021-08-31 | $81.30K 10-Q · filed 2022-10-18 | $149.05K derived: sum of 2 quarters · filed 2022-10-18 | $233.87K 10-Q · filed 2022-10-18 | $405.24K derived: sum of 4 quarters · filed 2022-10-18 |
| 2021-05-31 | $67.75K 10-Q · filed 2022-07-11 | $152.57K 10-Q · filed 2022-07-11 | $323.95K derived: sum of 3 quarters · filed 2022-07-11 | $485.94K derived: sum of 4 quarters · filed 2022-07-11 |
| 2021-02-28 | $84.82K 10-Q · filed 2022-04-13 | $256.19K derived: sum of 2 quarters · filed 2022-04-13 | $418.19K derived: sum of 3 quarters · filed 2022-04-13 | $482.68K derived: sum of 4 quarters · filed 2022-04-13 |
| 2020-11-30 | $171.37K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $333.37K derived: sum of 2 quarters · filed 2022-02-22 | $397.86K derived: sum of 3 quarters · filed 2022-02-22 | $622.12K 10-K · filed 2022-02-22 |
| 2020-08-31 | $161.99K 10-Q · filed 2021-10-15 | $226.49K derived: sum of 2 quarters · filed 2021-10-15 | $450.75K 10-Q · filed 2021-10-15 | $608.53K derived: sum of 4 quarters · filed 2021-10-15 |
| 2020-05-31 | $64.49K 10-Q · filed 2021-07-15 | $288.75K 10-Q · filed 2021-07-15 | $446.54K derived: sum of 3 quarters · filed 2021-07-15 | $460.71K derived: sum of 4 quarters · filed 2021-07-15 |
| 2020-02-29 | $224.26K 10-Q · filed 2021-04-14 | $382.05K derived: sum of 2 quarters · filed 2021-04-14 | $396.22K derived: sum of 3 quarters · filed 2021-04-14 | $483.05K derived: sum of 4 quarters · filed 2021-04-14 |
| 2019-11-30 | $157.79K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $171.96K derived: sum of 2 quarters · filed 2021-03-01 | $258.79K derived: sum of 3 quarters · filed 2021-03-01 | $397.77K 10-K · filed 2021-03-01 |
| 2019-08-31 | $14.17K 10-Q · filed 2020-10-15 | $101.00K derived: sum of 2 quarters · filed 2020-10-15 | $239.98K 10-Q · filed 2020-10-15 | $394.56K derived: sum of 4 quarters · filed 2020-10-15 |
| 2019-05-31 | $86.83K 10-Q · filed 2020-07-10 | $225.81K 10-Q · filed 2020-07-10 | $380.39K derived: sum of 3 quarters · filed 2020-07-10 | $435.80K derived: sum of 4 quarters · filed 2020-07-10 |
| 2019-02-28 | $138.98K 10-Q · filed 2020-04-14 | $293.56K derived: sum of 2 quarters · filed 2020-04-14 | $348.97K derived: sum of 3 quarters · filed 2020-04-14 | $61.77K derived: sum of 4 quarters · filed 2020-04-14 |
| 2018-11-30 | $154.58K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $209.99K derived: sum of 2 quarters · filed 2020-02-28 | -$77.22K derived: sum of 3 quarters · filed 2020-02-28 | $478.38K 10-K · filed 2020-02-28 |
| 2018-08-31 | $55.41K 10-Q · filed 2019-10-15 | -$231.80K derived: sum of 2 quarters · filed 2019-10-15 | $323.80K 10-Q · filed 2019-10-15 | |
| 2018-05-31 | -$287.21K 10-Q · filed 2019-07-15 | $268.39K 10-Q · filed 2019-07-15 | ||
| 2018-02-28 | $555.60K 10-Q · filed 2019-04-15 | |||
| 2017-11-30 | $971.73K 10-K · filed 2019-02-28 | |||
| 2016-11-30 | $1.77M 10-K · filed 2018-02-28 | |||
| 2015-11-30 | $621.80K 10-K · filed 2017-02-28 | |||
| 2014-11-30 | $498.14K 10-K · filed 2016-02-29 | |||
| 2013-11-30 | $426.01K 10-K · filed 2015-03-02 | |||
| 2012-11-30 | $1.48M 10-K · filed 2014-02-28 | |||
| 2011-11-30 | $461.96K 10-K · filed 2013-02-28 | |||
| 2010-11-30 | $219.74K 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |